Company Filing History:
Years Active: 2017
Title: The Innovative Mind of David C. Weaver
Introduction
David C. Weaver is a prominent inventor based in Franklin, TN, USA, known for his contributions to the field of pharmaceuticals. With a focus on melanocortin receptors, his work is crucial in developing treatments for obesity and obesity-related disorders. His pioneering spirit and dedication to research have made significant impacts in medical science.
Latest Patents
David C. Weaver holds a pivotal patent titled "Positive Allosteric Modulators for Melanocortin Receptors." This patent highlights the development of positive allosteric modulators, particularly those that enhance the activity of melanocortin receptors MC3R and MC4R. The patent addresses pharmaceutical compositions that include these modulators and outlines methods for treating conditions such as obesity and type 2 diabetes by administering effective amounts of these compounds.
Career Highlights
As a researcher at Vanderbilt University, Weaver has made significant strides in pharmacological research, particularly in understanding and manipulating melanocortin pathways. His efforts in developing innovative treatment options for metabolic disorders have garnered attention in the scientific community and underscore the importance of his work in advancing healthcare solutions.
Collaborations
Throughout his career, Weaver has collaborated with esteemed colleagues such as Roger D. Cone and Julien A. Sebag. These collaborations have enriched his research endeavors, fostering a multidisciplinary approach to tackling complex health issues, particularly those related to obesity and its metabolic consequences.
Conclusion
David C. Weaver exemplifies the spirit of innovation in medical research through his patented work on melanocortin receptors. His contributions not only pave the way for new treatment options but also inspire future research in the field. As the landscape of healthcare evolves, inventors like Weaver play a crucial role in creating solutions for pressing health challenges.